Articles by Hellen Berger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Hellen Berger

Report from Brazil

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.
May 2, 2013

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil

Brazil's major vaccine producer innovates with stem-cell research.
Mar 2, 2013

Brazil's major vaccine producer innovates with stem-cell research.

Report from Brazil

Brazil to locally produce HIV/AIDS antiretroviral drug atazavanir.
Jan 1, 2013

The health ministry of Brazil recently signed an agreement to obtain its production technology to locally develop the antiretroviral drug atazavanir sulfate.

Report from Brazil

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.
Sep 2, 2012

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

Report from Brazil

Brazil's generic-drug market is growing steadily.
Mar 2, 2012

Brazil's generic-drug market is growing steadily.

Report from Latin America

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.
Sep 2, 2011

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.

Report From Brazil

Brazil develops its first national plasma fractionation plant.
Mar 2, 2011

Brazil develops its first national plasma fractionation plant.

Report from Brazil

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
Sep 2, 2010

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.

Report from Brazil

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
May 2, 2010

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here